Fair value · MOLECULAR PARTNERS AG (MOLN) · updated 2026-09-12 · from 20-F FY2025
MOLECULAR PARTNERS trades at $4.08. We are not reading assumptions out of that price: financials are filed in CHF; our prices are in USD, so these methods need a conversion we do not yet publish.
Everything below is unaffected: the filed statements, the filing they came from, and MOLN’s growth history are all as reported.
The filing behind these numbers
MOLECULAR PARTNERS AG- Revenue
- CHF 0
- Diluted EPS
- CHF -1.65
- Free cash flow
- CHF -52.0M
- operating cash flow − capital expenditure
- Diluted shares
- 37.3M
- weighted average
20-F FY2025 · fiscal year ended 2025-12-31 · filed 2026-03-12 · accession 0001745114-26-000009
Open this filing on sec.govNeed MOLN data in your own agent or pipeline?
The valuation data behind this page — DCF fair value, margin of safety, PE vs industry, analyst estimates — is also available programmatically through the EvidInvest MCP server & financial data API for Claude, Cursor, or any MCP client and HTTP pipeline.